By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


InNexus Inc. 

Seattle  Washington    USA
Phone: 425-696-0068 Fax:



Company News
InNexus Inc. and Genhelix to Combine Antibody Development and Manufacturing Resources 7/10/2009 8:25:16 AM
InNexus Inc. Lead Candidate DXL625 Outperforms Rituxan in Additional Animal Studies 9/16/2008 11:44:18 AM
InNexus Inc. Enters R&D Agreement Targeting Cancer With BioInvent Of Sweden, Appoints New Chairman Of The Board Of Directors 9/27/2006 10:41:40 AM
InNexus Inc. Names New CEO 9/1/2006 3:10:54 PM
InNexus Inc. Announces Publication Of Scientific Review Of TransMab(TM) Technology10/19/2005 5:13:14 PM
InNexus Inc. Lists On NASD OTC Bulletin Board In The United States10/19/2005 5:12:33 PM
InNexus Inc. Names Morhet As Vice President Of Operations10/19/2005 5:12:19 PM
Innexus Biotechnology Inc. (IXS) And Epitomics, Inc. Enter Into A Co-Development Agreement For Therapeutic TransMab Antibodies10/19/2005 5:12:12 PM
InNexus Inc. Closes Private Placement For $940,50010/19/2005 5:12:06 PM
InNexus Inc. Announces A Scientific Discovery And Expansion Of Its SuperAntibody Intellectual Property10/19/2005 5:10:46 PM